Samuel J. Mackenzie, M.D., Ph.D.

Locations

Neurology

601 Elmwood Avenue, 1st Floor
Rochester, NY 14642

(585) 275-1200 Get Directions

Neuromuscular Electromyography and Nerve Conduction (EMG) Lab

919 Westfall Road, Suite 210
Rochester, NY 14618

(585) 275-4568

About Me

Professional Background

Dr. Mackenzie completed his undergraduate studies at Cornell University before earning a Master's degree in exercise science at the University of Delaware and his MD and PhD degrees at SUNY Upstate Medical University. He completed residency in child neurology at the University of Michigan and fellow...

Dr. Mackenzie completed his undergraduate studies at Cornell University before earning a Master's degree in exercise science at the University of Delaware and his MD and PhD degrees at SUNY Upstate Medical University. He completed residency in child neurology at the University of Michigan and fellowship in neuromuscular medicine at The Ohio State University and Nationwide Children's Hospital.

Certified Specialties

Neuromuscular Medicine

Faculty Appointments

Assistant Professor - Department of Neurology, NMD (SMD)

Assistant Professor - Department of Neuroscience (SMD) - Joint

Assistant Professor - Department of Pediatrics (SMD) - Joint

Credentials

Residency & Fellowship

Fellowship, Neuromuscular Medicine, Ohio State University Wexner Medical Center. 2020 - 2021

Residency, Pediatric Neurology, University of Michigan Medical School. 2017 - 2020

Internship, Pediatrics, University of Michigan Medical School. 2015 - 2017

Education

MD | SUNY Upstate College of Health Professions. 2015

Research

Dr. Mackenzie is a physician-scientist with clinical and research interests in pediatric neuromuscular disorders. His overall research goals involve bringing novel gene-based therapies to patients with rare conditions through a variety of basic and translational approaches. He recently received NIH-...

Dr. Mackenzie is a physician-scientist with clinical and research interests in pediatric neuromuscular disorders. His overall research goals involve bringing novel gene-based therapies to patients with rare conditions through a variety of basic and translational approaches. He recently received NIH-NINDS funding to study RNA-targeted oligonucleotides in murine models of myotonic dystrophy, currently serves as a sub-investigator on a phase III clinical trial for microdystrophin gene therapy for boys with Duchenne Muscular Dystrophy, and is among the nation's leading experts in TANGO2-related disorder, a rare disease caused by biallelic variants in the TANGO2 gene.